Tempest Therapeutics (TPST) EBIT Margin (2015 - 2018)
Tempest Therapeutics (TPST) posted EBIT Margin of -14192.73% for Q3 2018, up 2603.70 percentage points from -16796.43% a year earlier but down 8037.17 percentage points from the prior quarter.
Tempest Therapeutics (TPST) EBIT Margin (2015 - 2018) Analysis & Trends
For the trailing twelve months through Sep 30, 2018, EBIT Margin at Tempest Therapeutics was -20266.67%, down 423.77 percentage points year-over-year; for FY2017, it came in at -28585.08%, down 16178.96 percentage points from FY2016.
- In prior years, Tempest Therapeutics' EBIT Margin was -12406.13% in FY2016 (+13586.29 pp) and -25992.42% in FY2015.
- Quarterly EBIT Margin has run from a low of -112086.67% in Q1 2015 to a high of -6155.56% in Q2 2018 over five years.
- On a year-over-year basis, EBIT Margin has increased in each of the last three quarters, with an average year-over-year change of -3330.21 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2016, with a gain of 97402.42 percentage points; the weakest was Q4 2017, with a drop of 28111.85 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -6155.56% (Q2 2018), -6549.25% (Q1 2018) and -46597.80% (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Tempest Therapeutics | 4.09 Mn | -26.23 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -14,192.73% |
| Jun 30, 2018 | -6,155.56% |
| Mar 31, 2018 | -6,549.25% |
| Dec 31, 2017 | -46,597.80% |
| Sep 30, 2017 | -16,796.43% |
| Jun 30, 2017 | -21,345.24% |
| Mar 31, 2017 | -23,153.97% |
| Dec 31, 2016 | -18,485.95% |
| Sep 30, 2016 | -9,626.40% |
| Jun 30, 2016 | -9,651.32% |
| Mar 31, 2016 | -14,684.25% |
| Dec 31, 2015 | -12,891.72% |
| Sep 30, 2015 | -23,696.00% |
| Jun 30, 2015 | -57,246.67% |
| Mar 31, 2015 | -112,086.67% |
Tempest Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();